Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 23, 2025 • 2:30 AM ET

Date/Time Source News Release
06/02/2025 07:30 AM EDT GlobeNewswire Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05/30/2025 08:46 AM EDT GlobeNewswire Abeona Therapeutics® to Present at the Jefferies Global Healthcare Conference
05/15/2025 07:30 AM EDT GlobeNewswire Abeona Therapeutics® Reports First Quarter 2025 Financial Results and Corporate Updates
05/14/2025 08:07 AM EDT GlobeNewswire UPDATE -- Abeona Therapeutics® and Lurie Children's Open First Center for ZEVASKYN(TM) Gene Therapy to Treat Wounds in Painful Skin Disorder
05/14/2025 07:30 AM EDT GlobeNewswire Abeona Therapeutics® and Lurie Children's Open First Center for ZEVASKYNTM Gene Therapy to Treat Wounds in Painful Skin Disorder
05/12/2025 07:30 AM EDT GlobeNewswire Abeona Therapeutics® Enters into Agreement to Sell Priority Review Voucher for $155 Million
05/07/2025 04:59 PM EDT GlobeNewswire Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04/29/2025 06:00 AM EDT GlobeNewswire U.S. FDA Approves ZEVASKYN(TM) (prademagene zamikeracel), the First and Only Cell-Based Gene Therapy for Patients with Recessive Dystrophic Epidermolysis Bullosa (RDEB)
04/01/2025 07:30 AM EDT GlobeNewswire Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/20/2025 07:30 AM EDT GlobeNewswire Abeona Therapeutics® Reports Full Year 2024 Financial Results, Provides Pz-cel Regulatory Update and Commercial Launch Plans
Page

Additional News

As of June 23, 2025 • 2:30 AM ET

Date/Time Source News Release
06/16/2025 05:22 AM EDT SeekingAlpha Is Abeona Therapeutics' Zevaskyn Worth $3.1m Per Treatment, Or Will Krystal Biotech Remain The Market Leader?
06/11/2025 05:18 PM EDT SeekingAlpha Capricor: A Hold Rating With Regulatory FDA Form Given For Deramiocel Advancement
06/05/2025 05:48 AM EDT SeekingAlpha Abeona Therapeutics: Substantially Undervalued Post-FDA Approval (Rating Upgrade)
05/16/2025 05:30 AM EDT US Earnings Reports Expected earnings - Abeona Therapeutics Inc.
05/16/2025 01:37 AM EDT SeekingAlpha Abeona targets treating 10-14 ZEVASKYN patients in 2025 while securing $155M PRV sale to extend runway
05/16/2025 01:37 AM EDT SeekingAlpha Abeona Therapeutics Inc. (ABEO) Q1 2025 Earnings Call Transcript
05/15/2025 07:49 AM EDT SeekingAlpha Abeona Therapeutics GAAP EPS of -$0.24 beats by $0.12
05/07/2025 10:45 AM EDT KlickAnalytics DYN, HUN, GH, TTEK, ABEO showing five-day downward plunge
04/29/2025 06:40 AM EDT SeekingAlpha Abeona spikes on FDA nod for gene therapy
04/27/2025 08:30 AM EDT SeekingAlpha Undercovered Dozen: 3D Systems, Seritage, Topicus, Timken +
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.